Predict your next investment

Venture Capital
athertonventures.com

See what CB Insights has to offer

Investments

24

Portfolio Exits

3

Funds

2

About Atherton Venture Partners

Atherton Venture Partners, LLC (AVP) invests in healthcare, life science, and information technology companies. Current portfolio holdings focus primarily on companies that develop diagnostic devices, medical treatment procedures, and surgical instruments in the fields of sports medicine, cardiovascular and vascular medicine, as well as radiology and anesthesiology. Information technology investments focus on companies that develop software and operating systems for storage area networks (SANS) as well as Internet security.

Atherton Venture Partners Headquarter Location

1010 El Camino Real, Suite 300

Menlo Park, California, 94025,

United States

(650) 323-8357

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Atherton Venture Partners Investments

24 Investments

Atherton Venture Partners has made 24 investments. Their latest investment was in Niveus Medical as part of their Series B on August 8, 2014.

CBI Logo

Atherton Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/13/2014

Series B

Niveus Medical

$1.84M

No

1

8/1/2013

Convertible Note

Niveus Medical

$0.5M

Yes

1

6/29/2011

Series D

Novasom

$35M

No

1

8/18/2006

Series C

Subscribe to see more

$99M

Subscribe to see more

0

9/6/2004

Series D

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/13/2014

8/1/2013

6/29/2011

8/18/2006

9/6/2004

Round

Series B

Convertible Note

Series D

Series C

Series D

Company

Niveus Medical

Niveus Medical

Novasom

Subscribe to see more

Subscribe to see more

Amount

$1.84M

$0.5M

$35M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

0

0

Atherton Venture Partners Portfolio Exits

3 Portfolio Exits

Atherton Venture Partners has 3 portfolio exits. Their latest portfolio exit was Novasom on August 14, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/14/2019

Asset Sale

$99M

1

4/18/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/21/2007

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/14/2019

4/18/2019

9/21/2007

Exit

Asset Sale

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

0

Atherton Venture Partners Fund History

2 Fund Histories

Atherton Venture Partners has 2 funds, including Atherton Venture Fund II, LLC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/1/2000

Atherton Venture Fund II, LLC

Early-Stage Venture Capital

Closed

$10M

1

12/1/1998

Atherton Venture Fund I, LLC

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

3/1/2000

12/1/1998

Fund

Atherton Venture Fund II, LLC

Atherton Venture Fund I, LLC

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$10M

$99M

Sources

1

10

Atherton Venture Partners Team

1 Team Member

Atherton Venture Partners has 1 team member, including current Managing Partner, David M. Neubauer.

Name

Work History

Title

Status

David M. Neubauer

Managing Partner

Current

Name

David M. Neubauer

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.